Prevalence of Cervical Human Papillomavirus in Taiwanese Women

Chemg-Jye Jeng; Ma-Lee Ko; Qing-Dong Ling; Jenta Shen; Hui-Wen Lin; Chii-Ruey Tzeng; Chih-Ming Ho; Tsai-Yen Chien; Su-Chee Chen
October 2005
Clinical & Investigative Medicine;Oct2005, Vol. 28 Issue 5, p261
Academic Journal
Purpose: To define the prevalence rate of cervical human papilloma virus (HPV) using DNA oligonucleotide microarray and its correlation with risk factors in Taiwanese women in metropolitan Taipei. Methods: Thirteen hundred and twenty healthy women, aged 21 - 65 yr without history of cervical intraepithelial neoplasia (CIN) or carcinoma were included in this prospective study. Pap smear and HPV typing using oligonucleotide microarray were performed for each woman. They were given a standardized questionnaire to obtain information about the risk factors of cervical cancer in Taiwan. Results: The overall HPV positivity was 19.85% and multiple infections were found in 35.84% of the infected group, 7.92% of the whole study population. The younger the subject, the higher was the infection rate and multiple infection rates. The most common HPV types were 16, 18, 58, 52, 51 and 56, which is different from the western world. The sensitivity of the HPV DNA chip in detecting CIN and cervical carcinoma is 97.06%, and 100% in detecting CIN 2 or more lesions. Risk factors for HPV infection include earlier coitarche (P<0.01), multiple sexual partners (P<0.05), history of sexually transmitted disease (P<0.05), two or more vaginal deliveries (P<0.05) and infrequent use of condoms (P<0.05). The association between oral contraception or cigarette smoking and HPV infection could not be determined because few women smoke or used oral contraception. There was no relationship between induced abortion and HPV infection. Conclusions: About one-fifth of adult women in metropolitan Taipei were cervical HPV positive. The popular HPV types and the risk factors of HPV infection in metropolitan Taipei are not the same as those in the western world. The sensitivity of the HPV DNA chip in detecting cervical neoplasia is very high.


Related Articles

  • Vaccination against human papillomavirus in Switzerland: simulation of the impact on infection rates. Berchtold, André; Michaud, Pierre-André; Nardelli-Haefliger, Denise; Surís, Joan-Carles // International Journal of Public Health;Feb2010, Vol. 55 Issue 1, p25 

    Human papillomavirus (HPV) is a sexually transmitted infection of particular interest because of its high prevalence rate and strong causal association with cervical cancer. Two prophylactic vaccines have been developed and different countries have made or will soon make recommendations for the...

  • Pass the biscuits and watch your mouth. Stevens, Celia // MLO: Medical Laboratory Observer;Mar2003, Vol. 35 Issue 3, p4 

    Comments on the association of human papillomavirus (HPV) with cervical cancer. Increase in mortality rate of patient with the disease; Prevalence of sexually-transmitted disease in women; Advantage of DNA testing methods for HPV.

  • Papillomavirus.  // JAMA: Journal of the American Medical Association;5/8/2002, Vol. 287 Issue 18, p2452 

    Gives information about human papillomavirus (HPV), a group of viruses which cause papillomas, or flat growths called warts. Risk factors for HPV, including sexual contact with many partners; Cases of cancer of the cervix which are related to HPV infection; Preventing HPV infection, including...

  • THE STI YOU COULD ALREADY HAVE … and don't even know.  // Dolly;Apr2007, Issue 438, p136 

    The article presents information on human papilloma virus (HPV). Common warts are caused by some strains of HPV, genital warts are caused by other HPV strains and HPV of the cervix is caused by different strains again. HPV infection can be passed on by any sexual contact involving skin around...

  • Mothers' human papilloma virus knowledge and willingness to vaccinate their adolescent daughters in Lagos, Nigeria. Ezenwa, Beatrice N.; Balogun, Mobolanle R.; Okafor, Ifeoma P. // International Journal of Women's Health;2013, Vol. 5, p371 

    Introduction: Human papillomavirus (HPV) is one of the most common sexually transmitted infections in sexually active adolescents and young women and has been implicated as a cause of the majority of cases of cervical cancer, which is the second most common cancer in women in Nigeria. HPV is...

  • Human Papillomavirus Vaccines. Rand, Cynthia M.; Humiston, Sharon G.; Kennedy, William A. // Primary Care Reports;Sep2007, Vol. 13 Issue 9, p105 

    The article focuses on human papillomavirus (HPV) vaccines. HPV is the most common sexually transmitted infection in the U.S. Genital HPV is transmitted through genital contact, most often by vagina or anal intercourse, and infection usually occurs soon after sexual initiation. Some of the...

  • Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris. Bazan, Silvia Boschi; de Alencar Muniz Chaves, Agtha; Aires, Karina Araújo; Cianciarullo, Aurora Marques; Garcea, Robert L.; Ho, Paulo Lee // Archives of Virology;Oct2009, Vol. 154 Issue 10, p1609 

    Human papillomaviruses (HPVs) are responsible for the most common human sexually transmitted viral infections. Infection with high-risk HPVs, particularly HPV16, is associated with the development of cervical cancer. The papillomavirus L1 major capsid protein, the basis of the currently marketed...

  • Awareness and knowledge of HPV, cervical cancer, and vaccines in young women after first delivery in São Paulo, Brazil -- a cross-sectional study. Rama, Cristina H.; Villa, Luisa L.; Pagliusi, Sonia; Andreoli, Maria A.; Costa, Maria C.; Aoki, Aline L.; Longatto-Filho, Adhemar; Eluf-Neto, José // BMC Women's Health;2010, Vol. 10, p35 

    Background: The success of HPV vaccination programs will require awareness regarding HPV associated diseases and the benefits of HPV vaccination for the general population. The aim of this study was to assess the level of awareness and knowledge of human papillomavirus (HPV) infection, cervical...

  • a vaccine to prevent cancer. MacMillan, Amanda // Prevention;Jan2006, Vol. 58 Issue 1, p117 

    This article presents information about the clinical trial of a vaccine called Gardasil that targets the most common forms of cervical cancer caused by human papillomavirus (HPV), a sexually transmitted disease. While in college Lisa Kanning volunteered for the clinical study and now, nearing...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics